Kundan Edifice Board of Directors

Get the latest insights into the leadership at Kundan Edifice. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Divyansh Mukesh Gupta Managing Director
Ms. Mallika Mukesh Gupta Whole Time Director
Mr. Girish Kumar Joshi Independent Director
Mr. Satish Inani Independent Director
Mr. Hariom Sarda Independent Director

Kundan Edifice Share price

KEL

98.45

1.80 (1.86%)
NSE
BSE
Last updated on 4 Sep, 2025 | 12:15 IST
BUYSELL
Today's High

98.45

Today's Low

97.20

52 Week Low

91.00

52 Week High

186.95

The current prices are delayed, login to your account for live prices

Kundan Edifice FAQs

The board at Kundan Edifice consists of experienced professionals, including Mr. Divyansh Mukesh Gupta , Ms. Mallika Mukesh Gupta , and others, overseeing the company’s strategic and corporate governance.

Directors at Kundan Edifice are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Divyansh Mukesh Gupta is the current chairman at Kundan Edifice.

Executive directors at Kundan Edifice are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Kundan Edifice adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Kundan Edifice, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.